ArticleThe oncologist2015

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.

Carmelo Carlo-Stella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.